Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$104.10
-2.15-2.02%
At close: -
$104.10
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Axsome Therapeutics Analyst Ratings and Price Targets | NASDAQ:AXSM | Benzinga
Axsome Therapeutics Inc has a consensus price target of $162.68 based on the ratings of 19 analysts. The high is $216 issued by Mizuho on March 27, 2025. The low is $105 issued by UBS on August 6, 2024. The 3 most-recent analyst ratings were released by RBC Capital, HC Wainwright & Co., and Needham on June 12, 2025, June 10, 2025, and June 9, 2025, respectively. With an average price target of $172 between RBC Capital, HC Wainwright & Co., and Needham, there's an implied 65.23% upside for Axsome Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
HC Wainwright & Co.
Needham
Oppenheimer
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Axsome Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/12/2025 | Buy Now | 78.67% | RBC Capital | Leonid Timashev42% | $193 → $186 | Maintains | Outperform | Get Alert |
| 06/10/2025 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 06/09/2025 | Buy Now | 44.09% | Needham | Ami Fadia61% | $153 → $150 | Maintains | Buy | Get Alert |
| 06/03/2025 | Buy Now | 77.71% | Oppenheimer | Matthew Hershenhorn14% | → $185 | Initiates | → Outperform | Get Alert |
| 05/22/2025 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2025 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $200 → $180 | Maintains | Buy | Get Alert |
| 05/06/2025 | Buy Now | 58.5% | Wells Fargo | Cerena Chen41% | $160 → $165 | Maintains | Overweight | Get Alert |
| 05/06/2025 | Buy Now | 55.62% | Baird | Joel Beatty69% | $160 → $162 | Maintains | Outperform | Get Alert |
| 04/29/2025 | Buy Now | 85.4% | RBC Capital | Leonid Timashev42% | $190 → $193 | Maintains | Outperform | Get Alert |
| 04/07/2025 | Buy Now | 92.12% | Jefferies | Andrew Tsai28% | → $200 | Initiates | → Buy | Get Alert |
| 04/03/2025 | Buy Now | 92.12% | HC Wainwright & Co. | Raghuram Selvaraju44% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | 46.97% | Needham | Ami Fadia61% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2025 | Buy Now | 107.49% | Mizuho | Graig Suvannavejh52% | $212 → $216 | Maintains | Outperform | Get Alert |
| 03/06/2025 | Buy Now | 92.12% | HC Wainwright & Co. | Raghuram Selvaraju44% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | 46.97% | Needham | Ami Fadia61% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | 53.7% | Baird | Joel Beatty69% | $132 → $160 | Maintains | Outperform | Get Alert |
| 02/27/2025 | Buy Now | 82.52% | Morgan Stanley | Vikram Purohit37% | $125 → $190 | Maintains | Overweight | Get Alert |
| 02/26/2025 | Buy Now | 103.65% | Mizuho | Graig Suvannavejh52% | $195 → $212 | Maintains | Outperform | Get Alert |
| 02/25/2025 | Buy Now | 92.12% | HC Wainwright & Co. | Raghuram Selvaraju44% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | Buy Now | 46.97% | Needham | Ami Fadia61% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2025 | Buy Now | 92.12% | HC Wainwright & Co. | Raghuram Selvaraju44% | $190 → $200 | Maintains | Buy | Get Alert |
| 02/19/2025 | Buy Now | 92.12% | Truist Securities | Joon Lee77% | $190 → $200 | Maintains | Buy | Get Alert |
| 02/19/2025 | Buy Now | 84.44% | RBC Capital | Leonid Timashev42% | $143 → $192 | Maintains | Outperform | Get Alert |
| 02/19/2025 | Buy Now | 46.97% | Cantor Fitzgerald | Charles Duncan69% | $153 → $153 | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | 46.97% | Needham | Ami Fadia61% | $133 → $153 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | 53.7% | Wells Fargo | Cerena Chen41% | $140 → $160 | Maintains | Overweight | Get Alert |
| 02/11/2025 | Buy Now | 69.07% | Deutsche Bank | David Hoang42% | → $176 | Initiates | → Buy | Get Alert |
| 02/11/2025 | Buy Now | 60.42% | B of A Securities | Jason Gerberry64% | $143 → $167 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | 87.32% | Mizuho | Graig Suvannavejh52% | $137 → $195 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | 82.52% | HC Wainwright & Co. | Raghuram Selvaraju44% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | Buy Now | 44.09% | Leerink Partners | Marc Goodman73% | $110 → $150 | Maintains | Outperform | Get Alert |
| 02/10/2025 | Buy Now | 27.76% | Needham | Ami Fadia61% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 02/03/2025 | Buy Now | 31.6% | Mizuho | Graig Suvannavejh52% | $122 → $137 | Maintains | Outperform | Get Alert |
| 02/03/2025 | Buy Now | 82.52% | Truist Securities | Joon Lee77% | $180 → $190 | Maintains | Buy | Get Alert |
| 02/03/2025 | Buy Now | 37.37% | RBC Capital | Brian Abrahams50% | $139 → $143 | Maintains | Outperform | Get Alert |
| 01/31/2025 | Buy Now | 82.52% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $190 | Maintains | Buy | Get Alert |
| 01/29/2025 | Buy Now | 33.53% | RBC Capital | Brian Abrahams50% | $139 → $139 | Maintains | Outperform | Get Alert |
| 01/21/2025 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | 27.76% | Needham | Ami Fadia61% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | 72.91% | Truist Securities | Joon Lee77% | $150 → $180 | Maintains | Buy | Get Alert |
| 01/07/2025 | Buy Now | 34.49% | RBC Capital | Leonid Timashev42% | $138 → $140 | Maintains | Outperform | Get Alert |
| 01/06/2025 | Buy Now | 27.76% | Needham | Ami Fadia61% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 12/31/2024 | Buy Now | 17.2% | Mizuho | Graig Suvannavejh52% | $124 → $122 | Maintains | Outperform | Get Alert |
| 12/31/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju44% | — | Reiterates | Buy → Buy | Get Alert |
| 12/30/2024 | Buy Now | 24.88% | Needham | Ami Fadia61% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | Buy Now | 16.23% | Cantor Fitzgerald | Charles Duncan69% | $121 → $121 | Reiterates | Overweight → Overweight | Get Alert |
| 11/27/2024 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/25/2024 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 11.43% | Baird | Joel Beatty69% | $112 → $116 | Maintains | Outperform | Get Alert |
| 11/13/2024 | Buy Now | 24.88% | Needham | Ami Fadia61% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | 24.88% | Needham | Ami Fadia61% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 10/04/2024 | Buy Now | 25.84% | RBC Capital | Leonid Timashev42% | $130 → $131 | Maintains | Outperform | Get Alert |
| 09/20/2024 | Buy Now | 2.79% | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | Buy Now | 2.79% | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | Buy Now | 2.79% | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/06/2024 | Buy Now | 2.79% | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2024 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | Buy Now | 24.88% | Needham | Ami Fadia61% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 09/03/2024 | Buy Now | 34.49% | Wells Fargo | Cerena Chen41% | → $140 | Initiates | → Overweight | Get Alert |
| 08/22/2024 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 08/06/2024 | Buy Now | 0.86% | UBS | Ashwani Verma48% | $107 → $105 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | 24.88% | RBC Capital | Leonid Timashev42% | $131 → $130 | Maintains | Outperform | Get Alert |
| 08/06/2024 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $190 → $180 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | 1.83% | B of A Securities | Jason Gerberry64% | $95 → $106 | Upgrade | Neutral → Buy | Get Alert |
| 08/06/2024 | Buy Now | 24.88% | Needham | Ami Fadia61% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 08/05/2024 | Buy Now | 24.88% | Needham | Ami Fadia61% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 07/26/2024 | Buy Now | 2.79% | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 07/22/2024 | Buy Now | 25.84% | RBC Capital | Leonid Timashev42% | $131 → $131 | Reiterates | Outperform → Outperform | Get Alert |
| 07/22/2024 | Buy Now | 24.88% | Needham | Ami Fadia61% | → $130 | Initiates | → Buy | Get Alert |
| 07/18/2024 | Buy Now | -8.74% | B of A Securities | Jason Gerberry64% | $97 → $95 | Maintains | Neutral | Get Alert |
| 06/12/2024 | Buy Now | 1.83% | Mizuho | Graig Suvannavejh52% | $106 → $106 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2024 | Buy Now | 82.52% | HC Wainwright & Co. | Raghuram Selvaraju44% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2024 | Buy Now | 24.88% | RBC Capital | Leonid Timashev42% | $127 → $130 | Maintains | Outperform | Get Alert |
| 05/08/2024 | Buy Now | 1.83% | Mizuho | Graig Suvannavejh52% | $109 → $106 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | 82.52% | HC Wainwright & Co. | Raghuram Selvaraju44% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 20.08% | Citigroup | David Hoang42% | $127 → $125 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | 7.59% | Baird | Joel Beatty69% | $108 → $112 | Maintains | Outperform | Get Alert |
| 04/29/2024 | Buy Now | 10.47% | Morgan Stanley | Vikram Purohit37% | $90 → $115 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/10/2024 | Buy Now | 2.79% | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 04/02/2024 | Buy Now | 82.52% | HC Wainwright & Co. | Raghuram Selvaraju44% | $190 → $190 | Maintains | Buy | Get Alert |
| 03/28/2024 | Buy Now | 4.71% | Mizuho | Graig Suvannavejh52% | $108 → $109 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | 44.09% | Truist Securities | Joon Lee77% | → $150 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | 22.96% | RBC Capital | Leonid Timashev42% | $123 → $128 | Maintains | Outperform | Get Alert |
| 03/26/2024 | Buy Now | 22% | Citigroup | David Hoang42% | $125 → $127 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | 82.52% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $190 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | Buy Now | 3.75% | Baird | Joel Beatty69% | → $108 | Initiates | → Outperform | Get Alert |
| 03/04/2024 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2024 | Buy Now | 3.75% | Mizuho | Graig Suvannavejh52% | $112 → $108 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | 20.08% | Guggenheim | Yatin Suneja57% | $110 → $125 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | 18.16% | RBC Capital | Leonid Timashev42% | $126 → $123 | Maintains | Outperform | Get Alert |
| 02/21/2024 | Buy Now | -1.06% | Cantor Fitzgerald | Charles Duncan69% | $108 → $103 | Maintains | Overweight | Get Alert |
| 02/20/2024 | Buy Now | 3.75% | Cantor Fitzgerald | Charles Duncan69% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 02/16/2024 | Buy Now | 7.59% | Mizuho | Graig Suvannavejh52% | $90 → $112 | Maintains | Buy | Get Alert |
| 02/06/2024 | Buy Now | 6.63% | UBS | Ashwani Verma48% | → $111 | Initiates | → Buy | Get Alert |
| 01/25/2024 | Buy Now | 21.04% | RBC Capital | Leonid Timashev42% | → $126 | Initiates | → Outperform | Get Alert |
| 01/22/2024 | Buy Now | 3.75% | Cantor Fitzgerald | Charles Duncan69% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 01/16/2024 | Buy Now | 8.55% | Piper Sandler | David Amsellem74% | $90 → $113 | Maintains | Overweight | Get Alert |
| 12/26/2023 | Buy Now | 72.91% | HC Wainwright & Co. | Raghuram Selvaraju44% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2023 | Buy Now | 3.75% | Cantor Fitzgerald | Charles Duncan69% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
FAQ
What is the target price for Axsome Therapeutics (AXSM) stock?
The latest price target for Axsome Therapeutics (NASDAQ:AXSM) was reported by RBC Capital on June 12, 2025. The analyst firm set a price target for $186.00 expecting AXSM to rise to within 12 months (a possible 78.67% upside). 70 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Axsome Therapeutics (AXSM)?
The latest analyst rating for Axsome Therapeutics (NASDAQ:AXSM) was provided by RBC Capital, and Axsome Therapeutics maintained their outperform rating.
When was the last upgrade for Axsome Therapeutics (AXSM)?
The last upgrade for Axsome Therapeutics Inc happened on August 6, 2024 when B of A Securities raised their price target to $106. B of A Securities previously had a neutral for Axsome Therapeutics Inc.
When was the last downgrade for Axsome Therapeutics (AXSM)?
There is no last downgrade for Axsome Therapeutics.
When is the next analyst rating going to be posted or updated for Axsome Therapeutics (AXSM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axsome Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axsome Therapeutics was filed on June 12, 2025 so you should expect the next rating to be made available sometime around June 12, 2026.
Is the Analyst Rating Axsome Therapeutics (AXSM) correct?
While ratings are subjective and will change, the latest Axsome Therapeutics (AXSM) rating was a maintained with a price target of $193.00 to $186.00. The current price Axsome Therapeutics (AXSM) is trading at is $104.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
